MOUNTAIN VIEW, Calif.,
July 27 /PRNewswire-FirstCall/ -- MAP
Pharmaceuticals, Inc. (Nasdaq: MAPP) today announced that the
Company will participate in the following investor events in
August:
|
Wedbush Life Sciences MAC Best
Ideas: Management Access Conference
|
|
|
Tuesday, August 3, at 8:00 a.m.
ET in New York, New York
|
|
|
|
|
Bank of America Merrill Lynch
2010 Specialty Pharmaceuticals Conference
|
|
|
Thursday, August 12, at 1:40
p.m. ET in Southampton, New York
|
|
|
A live webcast of the events will be available on the Investor
Relations section of MAP Pharmaceuticals' website at
http://www.mappharma.com. A replay will also be available within 24
hours for seven days following the presentation.
About MAP Pharmaceuticals
MAP Pharmaceuticals is dedicated to developing and
commercializing new therapies for patients suffering from
conditions that are not adequately treated by currently available
medicines. The company is developing LEVADEX™ orally inhaled
therapy for the potential treatment of migraine and has reported
positive results from the efficacy portion of its Phase 3 trial of
LEVADEX. In addition, MAP Pharmaceuticals generates new pipeline
opportunities by applying its proprietary drug particle and
inhalation technologies to enhance the therapeutic benefits of
proven drugs, while minimizing risk by capitalizing on their known
safety, efficacy and commercialization history.
Additional information about MAP Pharmaceuticals can be found at
http://www.mappharma.com.
|
CONTACTS:
|
|
|
Lisa Borland
|
|
|
MAP Pharmaceuticals,
Inc.
|
|
|
(650) 386-3122
|
|
|
lborland@mappharma.com
|
|
|
SOURCE MAP Pharmaceuticals, Inc.